Accelerate your vaccine work with Kelly talent and workforce solutions

The timeline for developing a vaccine can span 16 years—from research, preclinical, and phase 1 – phase 3 trials, to building factories, manufacturing, approval, and distribution. Operation Warp Speed will condense that to one year, or even sooner. Kelly is ready to help you at any phase in the cycle. 

25+ years in all phases of vaccine development

Kelly Science & Clinical has been impacting the sciences with amazing talent for more than 25 years. That includes vaccine support for kit building, reagents, Dx and CLIA labs, state health departments, epidemiology, and clinical functions within all phases of drug development through manufacturing.

Where we’re helping to combat COVID

In fact, our employees have been actively engaged since the onset of COVID-19 from diagnosis and monitoring, to clinical trials and public safety, to vaccine manufacturing and distribution.

A true partner to science

Kelly Science & Clinical is an award-winning specialist known for sourcing superior clinical talent through a full range of flexible, efficient workforce solutions. We’re a true partner that enables your success.

Injecting vaccine science with the talent you need

Turn to us for immediate access to the qualified talent you’ll need to fill an influx of positions. We’ll quickly connect you to great people through our unique recruiting model, using 200+ recruiters across teams focused on science, engineering, and technology. We’ve already nurtured a pipeline of local and national talent. And we build customized solutions, from staffing to FSP, each designed to service your technical needs while keeping your business ahead of industry trends.

A few roles we’ve placed for the COVID-19 vaccine

• Scientists – with experience in bulk vaccine manufacturing, supporting  new process analytical technology (PAT) lab and laboratory operations
• Manufacturing Associates – with experience in assay execution, laboratory maintenance, GMP documentation, and assay monitoring of the vaccine propagation process
• Clinical Vaccines Program Managers – with backgrounds in vaccine development and CRO management, plus experience in novel technologies with specialties in mRNA, siRNA, RNAi, nucleic acid medicines, lipid-mediated delivery, and OTC deficiency
• Technology Transfer Leads – for efforts in technical development, manufacturing, and quality to sustain cGMP processes, with expertise for vaccine processes in both small- and large-scale manufacturing.